Immix Biopharma (IMMX) Exchange Rate Effect (2021 - 2026)
Immix Biopharma (IMMX) reported Exchange Rate Effect of -$12813.0 for Q1 2026, down 60.16% on a YoY basis from -$32163.2 in Q1 2025, and down 9.09% sequentially from -$11745.0 in Q4 2025.
Immix Biopharma (IMMX) Exchange Rate Effect (2021 - 2026) Analysis & Trends
Immix Biopharma (IMMX) has 6 years of Exchange Rate Effect data on file, last reported at -$12813.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 60.16% year-over-year to -$12813.0; the trailing twelve-month figure through Mar 2026 stood at -$971.0 (up 22.69% YoY), and the FY2025 full-year result was $3842.0, up 206.07% from the prior year.
- Exchange Rate Effect fell to -$12813.0 in Q1 2026, from -$11745.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $44139.0 in Q2 2025 to a low of -$25128.0 in Q4 2024.
- A 5-year average of -$648.53 and a median of -$5304.0 in 2022 frame the typical range for Exchange Rate Effect.
- Across the five-year window, Exchange Rate Effect jumped 20028.66% in 2023 and tumbled 1744.48% in 2024, its largest moves.
- Tracing IMMX's Exchange Rate Effect over 5 years: stood at -$157.0 in 2022, then jumped by 20028.66% to $31288.0 in 2023, then slumped by 180.31% to -$25128.0 in 2024, then soared by 53.26% to -$11745.0 in 2025, then declined by 9.09% to -$12813.0 in 2026.
- Business Quant data shows IMMX's Exchange Rate Effect at -$12813.0 in Q1 2026, -$11745.0 in Q4 2025, and -$20552.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 19.32 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Immix Biopharma | 473.68 Mn | 473.68 Mn | - | -12,813.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12,813.00 |
| Mar 31, 2026 | -12,813.00 |
| Dec 31, 2025 | -11,745.00 |
| Dec 31, 2025 | -11,745.00 |
| Sep 30, 2025 | -20,552.00 |
| Sep 30, 2025 | -20,552.00 |
| Jun 30, 2025 | 44,139.00 |
| Jun 30, 2025 | 44,139.00 |
| Mar 31, 2025 | -8,000.00 |
| Mar 31, 2025 | -8,000.00 |
| Dec 31, 2024 | -25,128.00 |
| Dec 31, 2024 | -25,128.00 |
| Sep 30, 2024 | 22,962.00 |
| Sep 30, 2024 | 22,962.00 |
| Jun 30, 2024 | 8,910.00 |
| Jun 30, 2024 | 8,910.00 |
| Mar 31, 2024 | -10,366.00 |
| Mar 31, 2024 | -10,366.00 |
| Dec 31, 2023 | 31,288.00 |
| Dec 31, 2023 | 31,288.00 |